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Abstract 
Many patients with chronic illnesses suffer from clinical depression (with percentages reported by clinical studies ranging 
from 15 to 60); even depression is more common in people with chronic medical illnesses, (e.g. Systemic Lupus Erythematosus) 
than in the general population. However, not every patient with a chronic illness suffers from depression. It is well known that some 
people think the persons who suffer from a chronic illness have a reason to be depressed, so, there is no need to go to a psychiatrist 
for treatment. The fact is that not only the medical condition can be the cause for depression and, not always, the treatment for a 
medical illness can supply the treatment for depression. The condition of clinical depression, associated with a chronic illness, needs 
to be early diagnosed and early treated because it can worsen the medical state. Systemic Lupus Erythematosus (SLE) is a chronic, 
autoimmune disease, which affects many organs and systems. The link between lupus and depression is controversial but it is 
known that negative life events, lupus activity and the treatment for disease may be capable of contributing to clinical depression. We 
present the case of a young woman who was diagnosed with Systemic Lupus Erythematosus and who initially presented in the 
psychiatric department for depressive symptoms. The case raised problems in terms of diagnosis, treatment, etiology and prognosis. 
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Introduction 
Systemic lupus erythematosus is a multi-
systemic disease of unknown etiology [1]. SLE is an 
autoimmune disease; the condition may vary widely in 
severity, from a simple skin rash, headaches to chorea 
and permanent paralysis. Neuro-psychiatric symptoms 
are frequent in SLE with a range between 13% to 75%.  
The psychiatric symptoms may vary from mild personality 
disorders to severe psychotic behavior. Shearn and 
Pirofsky found that endogenous depression is the most 
frequent mental change in lupus (about 50% of the 
patients develop depression) [2]. The management of 
depression in lupus rests on a combination of treating the 
underlying lupus itself as well as adding antidepressant 
therapy. 
Case presentation 
CD, 24 years old, university student, female. 
The patient smoked but evidently did not abuse 
of drugs or alcohol and was not taking any drugs before 
admission. The patient had no history of psychiatric 
illnesses; there was no known family history of psychiatric 
or autoimmune diseases. 
One month prior to the admission, she became 
sad, cried easily, had headaches, lost interest in the daily 
activities, presented heart palpitations and disturbance in 
sleep and appetite. The symptoms were worse day by 
day and she decided to call for a psychiatric consult. 
 
Psychiatric consult 
Patient was properly dressed, according to time 
and place. She was in a depressant mood, she had 
anhedonia, psychomotor retardation, thoughts of 
helplessness, hopelessness, low self-esteem, insomnia, 
fatigue. The patient said that she was unable to think or to 
act, but memory functions were not impaired. No auditory 
or visual hallucinations were detected.  
 
Physical examination 
Photosensitive butterfly rash on the face (the 
symptoms of malar rash and photosensitivity have been 
noted for about 5 months, by herself) and vasculitis 
lesions over her hands. She had alopecia and Raynaud’s 
phenomenon over both hands. Eye, ear and nose- in 
normal ranges. No lymphadenopathy was found. Oral 
ulceration of 1 cm diameter over the soft palate. Pain and 
restriction of the movement in her joints were found. 
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Heart and lungs- no significant abnormality. 
No palpable spleen and liver. 
 
Laboratory results 
-  WBC count: 8,150//￿L; 
-  Hb 10,2 gm/dL;  
-  ESR- 58 mm/hr; 
-  Platelet- 255,000/ mm3; 
-  EEG was normal; 
-  CT was normal; 
Suspecting an autoimmune disease, we asked 
for supplementary investigation: 
rheumatoid factor negative 
-  C3: 72,4 mg/dL (90-180mg/dL) 
-  C4:32 mg/dL (10-40mg/dL) 
-    T3, T4, TSH in normal ranges 
-     L.E. cell was positive  
-     Anti nuclear antibodies (ANA) negative. 
Taking into account all the dates, we started the 
treatment with Diazepam 10mg/day. Subsequently, she 
started the treatment with Prednisolone 60 mg/day and 
was sent to a medical clinic in order to have her evolution 
tracked. In a few days from the beginning of the treatment 
with Prednisolone, the patient developed other psychiatric 
symptoms such as agitation; logorrhea, suicidal ideation, 
confusion and illusions. The diagnosis was steroid 
induced psychosis and 2 mg of risperidonum was given. 
The symptoms disappeared completely in approximately 
2 months, in conditions of prednisone dosage reduction. 
The treatment with Risperidonum was interrupted after 2 
months. After this episode, no psychotic symptoms were 
present.  
After 3 months of follow-up the depressive 
symptoms persisted, and an antidepressant treatment 
was started (Duloxetine 60mg/day). After another 6 
months with prednisone 5 mg/day and Duloxetine 
60mg/day, the dose of Duloxetine was decreased at 30 
mg/day and after 2 months of stable mood and no 
significant symptoms of depression, it was eliminated.  
Discussion 
1. The case made the diagnostic criteria of the 
American Rheumatism Association [3] for SLE (alopecia, 
facial erythema, positive L.E. cells, oral ulceration, 
vasculitis and Raynaud’s phenomenon). What was 
unusual in this case is the fact that anti nuclear antibodies 
(ANA) were negative (a small group of patients develop 
clinical features remarkably similar to those of SLE, but 
never appear to develop ANA [4]). In our case, a test 
made after the initiation of the treatment with Prednisone 
showed ANA (+). 
2. Steroid psychosis often occurs from a few 
days to 2 weeks after the administration of this agent. 
Patients with steroid-induced psychosis often show mood 
disorders including logorrhea, distraction, confusion and 
hallucination. In our case, two factors of the ones which 
are considered to be major risk factors for steroid 
psychosis, namely being female and being administered 
Prednisolone 60 mg/day (more than 40 mg/day), were 
present. [5,6]  
The treatment of steroid psychosis involves 
dosage reduction or discontinuation of Prednisolone, but 
this usually cannot be done due to the severity of the 
underlying disease that requires Prednisolone. In such 
cases, we have to treat the patient with antipsychotic 
drugs. Tricyclic and tetracyclic antidepressants have been 
reported to induce exacerbation of agitation [6-8].  It is 
difficult to distinguish psychotic episodes caused by 
steroids from those caused by central nervous system 
disorders in collagen, but symptoms’ disappearance when 
the dose of Prednisone was decreased, made things clear 
about the symptoms developed shortly after the initiation 
of the treatment.  
3. The depressive episode is hard to be 
interpreted, because it was the reason that made the 
patient come to the doctor, however, it was not the only 
disorder found. The etiology of psychiatric manifestation 
of SLE is still unknown. We cannot say if it is a simple 
coincidence or the psychiatric symptoms can be 
explained as a part of the disease spectrum of SLE. The 
depression in SLE is frequent and it can be caused by the 
lupus itself, by various medications used to treat lupus 
and by other factors unrelated to lupus. Psychiatric 
disorders may merely be reactive psychological 
disturbances due to the stress related to the impact of 
having a chronic illness [9,10]. Supportive psychotherapy 
has been successful in helping many patients with SLE 
adjust to the limitation imposed by the disease [11]. 
Conclusions 
When a patient comes to a psychiatrist for some 
psychiatric symptoms we have to remember that a 
responsible physical examination must be done, because 
is easy to miss an organic disease. In our case, we can 
say that we are not talking about psychiatric symptoms as 
an initial feature of SLE, because the patient herself noted 
the malar rash, some months before she started having 
depressive symptoms. When we suspect a medical illness 
in our patients, we must collaborate with the other 
specialists in order to make an early diagnosis, which will 
lead to an early intervention. The treatment for depression 
in lupus consists of psychotropic medication, 
psychotherapy, and, most often a combination of both. 
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